The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...

Novo Nordisk A/S’s failure to meet its own bar for success on a next-generation obesity shot shows the danger of promising ...

In a brightly-lit gym in the Blanchardstown Campus sports hall, the Irish Futsal team gathers for its monthly training ...

A new study published Friday in the journal, JAMA Health Forum, found that obesity numbers ticked down slightly from 46% in 2022 to 45.6% in 2023. While only a slight decline, this is the first drop ...

These genes are crucial in breaking down stored fats and converting white fat into ... traditional food practices to address modern health challenges such as obesity and metabolic syndrome. With the ...

Earlier this fall, the Centers for Disease Control and Prevention reported data showing that adult obesity rates—long trending upwards—had fallen modestly over the past few years, from 41.9 to ...

I am not sure why you are getting so downvoted. The question is in my view a reasonable one. Studies suggest that the GLPs do lead to better cholesterol numbers, but if you have reasonably bad ...

Emerging evidence from the US has shown that a frequent intake of whole milk is associated with a lower risk of obesity. During the study, the team of researchers examined the diets of 43,038 adults ...

Obesity drugs like Wegovy are proving useful in many diseases. Polycystic ovary syndrome, a chronic condition that can cause infertility, may be one.

Obesity rates in Britain are soaring with nearly a quarter of adults now classed as clinically obese. Despite Government warnings that we are turning into a nation of couch potatoes and risking ...

For decades, researchers from all obesity-related disciplines have been observing the escalating prevalence of people living with overweight and obesity worldwide. Researchers always follow and ...

Eli Lilly & Co. is spending another $3 billion to build out its US manufacturing footprint as it ramps up production of its blockbuster diabetes and weight-loss drugs. The latest investment ...